Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: A meta-analysis and review of literature

Clinical Endocrinology

Volumn 80, Issue 6, 2014, Pages 797-803

  Shah, Viral N ^a   Shah, Chirag S ^b   Bhadada, Sanjay K ^c   Sudhakar Rao, D ^d  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; PHOSPHATE; VITAMIN D;

ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; DRUG SAFETY; HUMAN; META ANALYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RISK REDUCTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; TREATMENT OUTCOME; URINE;

ALKALINE PHOSPHATASE; CALCIUM; HUMANS; HYPERPARATHYROIDISM, PRIMARY; PHOSPHATES; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84899587068     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12398     Document Type: Article

References (29)

1. Moosgaard, B., Vestergaard, P., Heickendorff, L., et al,. (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clinical Endocrinology, 63, 506-513.
2. Boudou, P., Ibrahim, F., Cormier, C., et al,. (2006) A very high incidence of low 25- hydroxyvitamin D serum concentration in a French population of patients with primary hyperparathyroidism. Journal of Endocrinological Investigation, 29, 511-515.
3. Clements, M.R., Davies, M., Hayes, M.E., et al,. (1992) The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clinical Endocrinology, 37, 17-27.
4. Zierold, C., Mings, J.A., &, DeLuca, H.F., (2003) Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone. Journal of Cellular Biochemistry, 88, 234-237.
5. Rao, D.S., Agarwal, G., Talpos, G.B., et al,. (2002) Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. Journal of Bone and Mineral Research, 17 (Suppl 2), N75-N80.
6. Rao, D.S., Honasoge, M., Divine, G.W., et al,. (2000) Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. Journal of Clinical Endocrinology & Metabolism, 85, 1054-1058.
7. Stein, E.M., Dempster, D.W., Udesky, J., et al,. (2011) Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism. Bone, 48, 557-561.
8. Beyer, T.D., Chen, E., Nilubol, N., et al,. (2007) Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxyvitamin D insufficiency. Journal of Surgical Research, 143, 145-150.
9. Walker, M.D., Fleischer, J.B., Di Tullio, M.R., et al,. (2010) Cardiac structure and diastolic function in mild primary hyperparathyroidism. Journal of Clinical Endocrinology & Metabolism, 95, 2172-2179.
10. Zahrani, A.A., &, Levin, M.A., (1997) Primary hyperparathyroidism. Lancet, 349, 1233-1238.
11. Silverberg, S.J., Shane, E., Jacobs, T.P., et al,. (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. New England Journal of Medicine, 341, 1249-1255.
12. Eastell, R., Arnold, A., Brandi, M.L., et al,. (2009) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Journal of Clinical Endocrinology & Metabolism, 94, 340-350.
13. Bollerslev, J., Marcocci, C., Sosa, M., et al,. (2011) Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. European Journal of Endocrinology, 165, 851-864.
14. LoCascio, V., Adami, S., Galvanini, G., et al,. (1985) Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism. New England Journal of Medicine, 313, 1123-1125.
15. Kantorovich, V., Gacad, M.A., Seeger, L.L., et al,. (2000) Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. Journal of Clinical Endocrinology & Metabolism, 85, 3541-3543.
16. Grey, A., Lucas, J., Horne, A., et al,. (2005) Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. Journal of Clinical Endocrinology & Metabolism, 90, 2122-2126.
17. Grubbs, E.G., Rafeeq, S., Jimenez, C., et al,. (2008) Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery, 144, 852-858.
18. Isidro, M.L., &, Ruano, B., (2009) Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency. Endocrine, 36, 305-310.
19. Tucci, J.R., (2009) Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D. European Journal of Endocrinology, 161, 189-193.
20. Velayoudom-Cephise, F.L., Foucan, L., Soudan, B., et al,. (2011) Half of the patients with primary hyperparathyroidisms have a vitamin D deficiency: aggravating the osseous attack. Presse Medicale (Paris, France: 1983), 40, e120-e127.
21. Rathi, M., Gonzalez, S., &, Peacey, S., (2011) Management of hypovitaminosis D in patients with primary hyperparathyroidism. Endocrine Abstracts 25, P4.
22. Shkolnik, L.T., Drori, R., Schiller, T., et al,. (2010) Implications of Vitamin D status in patients with primary hyperparathyroidism. Journal of Bone and Mineral Research 25 (suppl 1). Available at http://www.asbmr.org/Meetings/ AnnualMeeting/AbstractDetail.aspx?aid=990e4d62-b722-460c-939d-7fca131b9245. accessed 12 January 2012.
23. Rao, R.R., Randeva, H.S., Sankaranarayanan, S., et al,. (2012) Prolonged treatment with vitamin D in postmenopausal women with primary hyperparathyroidism. Endocrine connections, 1, 13-21.
24. Lind, L., Wengle, B., Sørensen, O.H., et al,. (1989) Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism. Acta Endocrinologica, 120, 250-256.
25. Netelenbos, J.C., Asscheman, H., Lips, P., et al,. (1986) Absence of effect of 24,25-dihydroxyvitamin D3 in primary hyperparathyroidism. Journal of Clinical Endocrinology & Metabolism, 63, 246-248.
26. Jithpratuck, W., Garrett, L.H., &, Peiris, A.N., (2011) Treating vitamin D insufficiency in primary hyperparathyroidism: a cautionary tale. Tennessee Medicine, 104, 47-49.
27. Silverberg, S.J., (2000) Natural history of primary hyperparathyroidism. Endocrinology and Metabolism Clinics of North America, 29, 451-464.
28. Rolighed, L., Rejnmark, L., Sikjaer, T., et al,. (2013) Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. Journal of Bone and Mineral Research 28 (Suppl 1). Available at http://www.asbmr.org/asbmr-2013-abstract-detail?aid=3b2b0c24-89c7-45ea-9ebd- a704024a3575. accessed 9 December 2013.
29. Reid, I.R., Bolland, M.J., &, Grey, A., (2013) Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. doi: 10.1016/S0140-6736(13)61647-5.